This Article Free Full Text (Free PDF) Free All Versions of this Article: 0269881105056999v1 0269881105056999v2 20/1/128 0269881105056999v3    most recent References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (3) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Farrelly, N. Articles by Hunt, N. Search for Related Content PubMed PubMed Citation Articles by Farrelly, N. Articles by Hunt, N. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Bipolar Disorder Hazardous Substances DB LITHIUM COMPOUNDS LITHIUM, ELEMENTAL Social Bookmarking                         What's this?

Current management of bipolar affective disorder: Is it reflective of the BAP guidelines?

Harvard Bipolar Clinic and Research Program, Massachusetts General Hospital, 50 Staniford Street, Suite 580, Boston MA 02114, USA

C. Dibben

George McKenzie House, Fulbourn Hospital, Cambridge CB1 5EF, UK

N. Hunt

George McKenzie House, Fulbourn Hospital, Cambridge CB1 5EF, UK, Neil.Hunt{at}cambsmh.nhs.uk

In October 2003 the British Association of Psychopharmacology (BAP) published evidence-based guidelines on the management of bipolar disorder. The aim of this study was to assess whether the guidelines could provide the basis for examining clinical decisions and the extent to which practice accords with these guidelines. Case notes of out patients with bipolar disorder were reviewed. Demographic details, and treatment recommendations were determined. The management of affective episodes was evaluated and compared with BAP guidelines. In 84 subjects, 224 affective episodes were identified. Treatment was consistent with BAP guidelines in 72% of episodes. Mania was more likely to be managed in accordance with guidelines than depression or mixed episodes. The use of antidepressant medication was the most likely intervention to deviate from recommendations. Reasons for treatments at odds with the guidelines were identified. Our study demonstrates that clinical practice among a range of psychiatrists broadly reflects the guidelines that have been issued by the British Association of Psychopharmacology (BAP). The BAP guidelines offer a practical and auditable basis for the short- and long-term treatment of bipolar affective disorder.

Key Words: bipolar disorder • mania • depression • evidence-based guidelines • clinical practice

A more recent version of this article appeared on February 14, 2006
This version was published on January 1, 2006

Journal of Psychopharmacology, Vol. 20, No. 1, 128-131 (2006)
DOI: 10.1177/0269881105056999


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. S. Bauer, K. Biswas, and A. M. Kilbourne Enhancing Multiyear Guideline Concordance for Bipolar Disorder Through Collaborative Care Am J Psychiatry, November 1, 2009; 166(11): 1244 - 1250. [Abstract] [Full Text] [PDF]

				S Beynon, K Soares-Weiser, N Woolacott, S Duffy, and J. Geddes Pharmacological interventions for the prevention of relapse in bipolar disorder: a systematic review of controlled trials J Psychopharmacol, July 1, 2009; 23(5): 574 - 591. [Abstract] [PDF]